Retreatment with intravenous immunoglobulin (IVIG) of refractory Guillain Barre syndrome in children
Guillain-Barré syndrome (GBS) is an acute symmetrical pa- ralyzing disease due to a demyelinating polyrradiculoneuropathy, often induced by a preceding infection 1. The main modalities for the treatment of GBS include plasmapheresis and intrave- nous immune globulin. Reports of the use of IVIG in c...
Saved in:
Main Authors: | Rivas Larrauri Francisco (Author), Dávila Gutiérrez Guillermo (Author) |
---|---|
Format: | Book |
Published: |
Instituto Nacional de Pediatría,
2014-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome
by: J Gordon Millichap
Published: (2010) -
Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome
by: Chainani Ashok, et al.
Published: (2011) -
Uses of Intravenous Immunoglobulin: A 13-Year Evaluation of Guillain-Barré Syndrome in Fez, Morocco
by: F El Hilali, et al.
Published: (2017) -
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments
by: Shujuan Li, et al.
Published: (2014) -
Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG).
by: Julia Kostka, et al.
Published: (2024)